Akonni

Akonni develops, manufactures and markets integrated molecular diagnostic systems for clinical and life science research markets. Read more

174 Followers on Owler
174 Followers on Owler
174 Followers on Owler
174 Followers on Owler

Akonni

Akonni develops, manufactures and markets integrated molecular diagnostic systems for clinical and life science research markets. Read more

Jon Davis's photo - President of Akonni

President

Jon Davis

CEO Approval Rating

82/100

Founded:

2003

Status:

PrivateIndependent Company

AKONNI TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

OpGen is seen as one of Akonni's biggest rivals. OpGen is headquartered in Gaithersburg, Maryland, and was founded in 2002. Like Akonni, OpGen also works within the Biotechnology sector. OpGen generates 69% the revenue of Akonni.

AutoGenomics is seen as one of Akonni's top competitors. AutoGenomics was founded in 1999, and its headquarters is in Carlsbad, California. AutoGenomics operates in the Biotechnology industry. AutoGenomics has 54 more employees than Akonni.

Contextual Genomics is one of Akonni's top rivals. Contextual Genomics is a Private company that was founded in Vancouver, British Columbia in 2012. Contextual Genomics operates in the Biotechnology industry. Contextual Genomics has 7 more employees vs. Akonni.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Mobidiag a competitor of Akonni?

Akonni Acquisitions

No recent acquisitions found related to Akonni

Akonni Funding History

Since Akonni was founded in 2003, it has participated in 13 rounds of funding. In total Akonni has raised $32.4M. Akonni's last funding round was on Apr 2020 for a total of $350.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$350K - $1M
Debt
Jun 2019
$1.8M
-
Grant
Feb 2019
$3M
-
Equity
Jul 2018
$1.1M
-
Equity
Feb 2018
$7.5M
-

Since Akonni was founded in 2003, it has participated in 13 rounds of funding. In total Akonni has raised $32.4M. Akonni's last funding round was on Apr 2020 for a total of $350.0K

Akonni Investments

No recent investments found related to Akonni

Akonni News

December 27, 20184-traders

Akonni Biosystems to Participate in Corporate Access Event in San Francisco, January 7-9, 2019

(marketscreener.com) FREDERICK, Md., Dec. 27, 2018 (GLOBE NEWSWIRE) -- Akonni Biosystems, a molecular... See more »
December 11, 2018BioPortfolio

Akonni Biosystems Inc Product Pipeline Analysis 2018 Update Report Updated 06122018 Prices from USD $750

SummaryAkonni Biosystems Inc Akonni Biosystems is a molecular diagnostics company that develops manuf... See more »
August 22, 2018Pharmabiz

Akonni Biosystems gets $3 million SBIR grant from NIH to advance point─of─care diagnostic platform

Akonni Biosystems, a molecular diagnostics (MDx) company, announced receipt of a $3 million Small Bus... See more »
March 22, 2018SpaceGab

Akonni Biosystems Announces Strategic Partnership with Major Chinese Diagnostics Company Righton

"... we believe that our strongest path forward to commercialize Akonni's products and provide the mo... See more »
March 21, 2018BioPortfolio

Akonni and Righton Form TwoWay USChina Diagnostics Deal

Akonni Biosystems of Maryland and Righton a China in vitro diagnostics company announced a twoway com... See more »

Akonni Press Releases

July 5, 2017PRWeb

Akonni Biosystems Elects Brian J. Morra as Executive Chairman of the Board

Executive with Successful Entrepreneurial Track Record and Large Company Experience Elected to Suppor... See more »
March 13, 2017Press Release Rocket

Akonni Biosystems Awarded NIH Contract to Develop a Simple, Cost-Effective Device to Purify DNA from Sputum for Tuberculosis Testing

New device to provide solution for DNA extraction in remote settings Frederick, MD (PRWEB) March 14, ... See more »
February 13, 2017PRWeb

Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments

New hires round out commercialization staff.(PRWeb February 14, 2017)Read the full story at http://ww... See more »
November 23, 2016Blackbird

Global Tuberculosis Diagnostics and Treatment Market - Analysis, Trends & Forecasts to 2025 - Research and Markets

DUBLIN-(BUSINESS WIRE)-Research and Markets has announced the addition of the "Global Tuberculosis Di... See more »
May 26, 2016PR Newswire

Global Market and Potential for Molecular Point of Care Diagnostics Report 2016 - Research and Markets

DUBLIN, May 26, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "The Mark... See more »
February 5, 2016NewsMaker

Immunochemistry Analyzers Medical Devices Pipeline Assessment, 2015

WiseGuyReports.com adds "Immunochemistry Analyzers Medical Devices Pipeline Assessment 2015" report t... See more »

Social Media

Akonni Headquarters

400 Sagner Avenue Suite 300

Frederick, Maryland21701

1-301-698-0101

Driving Directions »

Trending Companies

Akonni Summary

ABOUT

Overview

Akonni develops, manufactures and markets integrated molecular diagnostic systems for clinical and life science research markets. Akonni was founded in 2003. Akonni's headquarters is located in Frederick, Maryland, USA 21701. It has raised 32.4M in 13...

CEO

Akonni's President, Jon Davis, currently has an approval rating of 82%. Akonni's primary competitors are OpGen, AutoGenomics & Contextual Genomics.

Website

akonni.com

Frequently Asked Questions about Akonni

  1. When was Akonni founded?

    Akonni was founded in 2003
  2. Who is Akonni's CEO?

    Akonni's CEO is Jon Davis
  3. How much revenue does Akonni generate?

    Akonni generates $6.1M in revenue
  4. How much funding does Akonni have?

    Akonni has historically raised $32.4M in funding
  1. Where is Akonni's headquarters?

    Akonni's headquarters is in Frederick Maryland, USA
  2. How many employees does Akonni have?

    Akonni has 43 employees
  3. What sector does Akonni operate in?

    Akonni is in Biotechnology, Pharmaceuticals
  4. Who are Akonni's competitors?

    Akonni's top competitors are OpGen, AutoGenomics, Contextual Genomics